Drugs / GD-iExo-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05969717 | Apr 2023 → Apr 2025 | atopic eczema | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GD-iExo-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05969717 ↗ |
| Route | Topical | “One drop (about 50 μL) of GD-iExo-001 was given to the affected skin area of 2-4 cm2 for 14 consecutive days, twice per day.” NCT05969717 ↗ |